Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-03

FDA Approved: ISOPROTERENOL HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved an original ANDA for Isoproterenol hydrochloride from Sagent Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isoproterenol hydrochloride (Isoproterenol hydrochloride)

Snippet

ORIG AP for ISOPROTERENOL HYDROCHLORIDE (ISOPROTERENOL HYDROCHLORIDE)